These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 29892041)

  • 1. Effectiveness of vitamin D therapy in improving metabolomic biomarkers in obesity phenotypes: Two randomized clinical trials.
    Bagheri M; Djazayery A; Qi L; Yekaninejad MS; Chamari M; Naderi M; Ebrahimi Z; Koletzko B; Uhl O; Farzadfar F
    Int J Obes (Lond); 2018 Oct; 42(10):1782-1796. PubMed ID: 29892041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity-Related Metabolomic Profiles and Discrimination of Metabolically Unhealthy Obesity.
    Bagheri M; Farzadfar F; Qi L; Yekaninejad MS; Chamari M; Zeleznik OA; Kalantar Z; Ebrahimi Z; Sheidaie A; Koletzko B; Uhl O; Djazayery A
    J Proteome Res; 2018 Apr; 17(4):1452-1462. PubMed ID: 29493238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma metabolomic profiling of amino acids and polar lipids in Iranian obese adults.
    Bagheri M; Djazayery A; Farzadfar F; Qi L; Yekaninejad MS; Aslibekyan S; Chamari M; Hassani H; Koletzko B; Uhl O
    Lipids Health Dis; 2019 Apr; 18(1):94. PubMed ID: 30967146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolically healthy/unhealthy components may modify bone mineral density in obese people.
    Mirzababaei A; Mirzaei K; Khorrami-Nezhad L; Maghbooli Z; Keshavarz SA
    Arch Osteoporos; 2017 Oct; 12(1):95. PubMed ID: 29082431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does the Metabolically Healthy Obese Phenotype Protect Adults with Class III Obesity from Biochemical Alterations Related to Bone Metabolism?
    Marques Loureiro L; Lessa S; Mendes R; Pereira S; Saboya CJ; Ramalho A
    Nutrients; 2019 Sep; 11(9):. PubMed ID: 31489911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No Difference in Lactoferrin Levels between Metabolically Healthy and Unhealthy Obese Women.
    Jamka M; Krzyżanowska-Jankowska P; Mądry E; Lisowska A; Bogdański P; Walkowiak J
    Nutrients; 2019 Aug; 11(9):. PubMed ID: 31443387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of incident obesity phenotype in nonobese healthy adults.
    Eftekharzadeh A; Asghari G; Serahati S; Hosseinpanah F; Azizi A; Barzin M; Mirmiran P; Azizi F
    Eur J Clin Invest; 2017 May; 47(5):357-365. PubMed ID: 28294315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolically healthy obesity, vitamin D, and all-cause and cardiometabolic mortality risk in NHANES III.
    Al-Khalidi B; Kimball SM; Kuk JL; Ardern CI
    Clin Nutr; 2019 Apr; 38(2):820-828. PubMed ID: 29525513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D status is not related to insulin resistance in different phenotypes of moderate obesity.
    Al Masri M; Romain AJ; Boegner C; Maimoun L; Mariano-Goulart D; Attalin V; Leprieur E; Picandet M; Avignon A; Sultan A
    Appl Physiol Nutr Metab; 2017 Apr; 42(4):438-442. PubMed ID: 28177726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular risk in different obesity phenotypes over a decade follow-up: Tehran Lipid and Glucose Study.
    Mirzaei B; Abdi H; Serahati S; Barzin M; Niroomand M; Azizi F; Hosseinpanah F
    Atherosclerosis; 2017 Mar; 258():65-71. PubMed ID: 28213199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inadequacy of Vitamin D Nutritional Status in Individuals with Metabolically Unhealthy Obesity Phenotype: The Relevance of Insulin Resistance.
    Cordeiro A; Campos B; Pereira SE; Saboya CJ; Ramalho A
    Diabetes Metab Syndr Obes; 2020; 13():4131-4139. PubMed ID: 33177853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver enzymes and vitamin D levels in metabolically healthy but obese individuals: Korean National Health and Nutrition Examination Survey.
    Hong HC; Lee JS; Choi HY; Yang SJ; Yoo HJ; Seo JA; Kim SG; Kim NH; Baik SH; Choi DS; Choi KM
    Metabolism; 2013 Sep; 62(9):1305-12. PubMed ID: 23643404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between Liver Enzymes with Metabolically Unhealthy Obese Phenotype.
    Xie J; Zhang S; Yu X; Yang Y; Liu Z; Yuan G; Hu S
    Lipids Health Dis; 2018 Aug; 17(1):198. PubMed ID: 30134916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myostatin and adipokines: The role of the metabolically unhealthy obese phenotype in muscle function and aerobic capacity in young adults.
    Carvalho LP; Basso-Vanelli RP; Di Thommazo-Luporini L; Mendes RG; Oliveira-Junior MC; Vieira RP; Bonjorno-Junior JC; Oliveira CR; Luporini R; Borghi-Silva A
    Cytokine; 2018 Jul; 107():118-124. PubMed ID: 29246653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiometabolic profiles and proteomics associated with obesity phenotypes in a longitudinal cohort of young adults.
    Liao J; Goodrich JA; Chen W; Qiu C; Chen JC; Costello E; Alderete TL; Chatzi L; Gilliland F; Chen Z
    Sci Rep; 2024 Mar; 14(1):7384. PubMed ID: 38548792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium plus vitamin D supplementation affects glucose metabolism and lipid concentrations in overweight and obese vitamin D deficient women with polycystic ovary syndrome.
    Asemi Z; Foroozanfard F; Hashemi T; Bahmani F; Jamilian M; Esmaillzadeh A
    Clin Nutr; 2015 Aug; 34(4):586-92. PubMed ID: 25300649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolically Obese Individuals of Normal Weight Have a High Risk of 25-Hydroxyvitamin D Deficiency.
    Wang X; Chang X; Zhu Y; Wang H; Sun K
    Am J Med Sci; 2016 Oct; 352(4):360-367. PubMed ID: 27776717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mediterranean diet and mortality risk in metabolically healthy obese and metabolically unhealthy obese phenotypes.
    Park YM; Steck SE; Fung TT; Zhang J; Hazlett LJ; Han K; Merchant AT
    Int J Obes (Lond); 2016 Oct; 40(10):1541-1549. PubMed ID: 27339604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of high-dose vitamin D supplementation on cardiometabolic risk factors in subjects with metabolic syndrome: a randomized controlled double-blind clinical trial.
    Salekzamani S; Mehralizadeh H; Ghezel A; Salekzamani Y; Jafarabadi MA; Bavil AS; Gargari BP
    J Endocrinol Invest; 2016 Nov; 39(11):1303-1313. PubMed ID: 27400997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of vitamin D3 supplementation on serum 25(OH)D, lipids and markers of insulin resistance in obese adolescents: a prospective, randomized, placebo-controlled pilot trial.
    Nader NS; Aguirre Castaneda R; Wallace J; Singh R; Weaver A; Kumar S
    Horm Res Paediatr; 2014; 82(2):107-12. PubMed ID: 25034315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.